Retatrutide

• >95%: Ideal for in vitro bioassays, in vivo biological activity tests, and Phase I and early Phase II clinical trials.
• >98%: Meets pharma-cGMP standards with defined impurity specifications, suitable for late Phase II, Phase III clinical trials, and commercial use.

This product is for scientific research only. It is a +99% pure lyophilized pharmacy grade powder in a sealed, sterile vial, with the total weight indicated on the label. Product appearance, label, seal, and cap colors may vary slightly from the images shown. Additional supplies are required.

Retatrutide Articles, Studies and Clinical Trials

• Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial
• Unleashing the power of retatrutide: A possible triumph over obesity and overweight
• A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity